These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroactive steroids in depression and anxiety disorders: clinical studies. Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334 [TBL] [Abstract][Full Text] [Related]
4. Neuroactive steroids as endogenous modulators of anxiety. Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729 [TBL] [Abstract][Full Text] [Related]
5. Breakthroughs in neuroactive steroid drug discovery. Blanco MJ; La D; Coughlin Q; Newman CA; Griffin AM; Harrison BL; Salituro FG Bioorg Med Chem Lett; 2018 Jan; 28(2):61-70. PubMed ID: 29223589 [TBL] [Abstract][Full Text] [Related]
6. Stress responsive neurohormones in depression and anxiety. Ströhle A; Holsboer F Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081 [TBL] [Abstract][Full Text] [Related]
7. Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effects. Korinek M; Kapras V; Vyklicky V; Adamusova E; Borovska J; Vales K; Stuchlik A; Horak M; Chodounska H; Vyklicky L Steroids; 2011 Dec; 76(13):1409-18. PubMed ID: 21925193 [TBL] [Abstract][Full Text] [Related]
8. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354 [TBL] [Abstract][Full Text] [Related]
9. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Cutler AJ; Mattingly GW; Maletic V Transl Psychiatry; 2023 Jun; 13(1):228. PubMed ID: 37365161 [TBL] [Abstract][Full Text] [Related]
11. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety]. Ströhle A Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245 [TBL] [Abstract][Full Text] [Related]
12. Regional brain volume in depression and anxiety disorders. van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116 [TBL] [Abstract][Full Text] [Related]
13. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Zheng P Prog Neurobiol; 2009 Oct; 89(2):134-52. PubMed ID: 19595736 [TBL] [Abstract][Full Text] [Related]
14. Glutamatergic NMDA Receptor as Therapeutic Target for Depression. Réus GZ; Abelaira HM; Tuon T; Titus SE; Ignácio ZM; Rodrigues AL; Quevedo J Adv Protein Chem Struct Biol; 2016; 103():169-202. PubMed ID: 26920690 [TBL] [Abstract][Full Text] [Related]
15. Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression. Benson C; Mifflin K; Kerr B; Jesudasan SJ; Dursun S; Baker G Mod Trends Pharmacopsychiatry; 2015; 30():67-79. PubMed ID: 26437459 [TBL] [Abstract][Full Text] [Related]
16. Emerging role of glutamate in the pathophysiology of major depressive disorder. Hashimoto K Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Eser D; Schüle C; Romeo E; Baghai TC; di Michele F; Pasini A; Zwanzger P; Padberg F; Rupprecht R Psychopharmacology (Berl); 2006 Jun; 186(3):373-87. PubMed ID: 16247651 [TBL] [Abstract][Full Text] [Related]
18. Neuroactive steroids as modulators of depression and anxiety. Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959 [TBL] [Abstract][Full Text] [Related]